Employment and Quality of Life in Patients With Malignant Melanoma
NCT ID: NCT02668887
Last Updated: 2019-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
221 participants
OBSERVATIONAL
2016-04-30
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors
NCT03326973
Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma
NCT01482260
Study of Families With Melanoma
NCT00445783
Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases
NCT00264056
Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors
NCT03946007
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality of Life, status of employment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
Exclusion Criteria
* inability to follow the protocol
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universität Münster
OTHER
Deutsche Rentenversicherung
OTHER
Fachklinik Hornheide an der Universität Münster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Susanne Dugas-Breit
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hans-Joachim Schulze, M.D.
Role: STUDY_DIRECTOR
Fachklinik Hornheide
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fachklinik Hornheide
Münster, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hornheide-Derm-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.